Aminoglycoside nephrotoxicity revisited

Journal, Indian Academy of Clinical Medicine

Volumn 8, Issue 4, 2007, Pages 331-333

  Sandhu, J S ^a   Sehgal, A ^a   Gupta, O ^a   Singh, A ^a  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE;

AMINOGLYCOSIDE INDUCED NEPHROTOXICITY; ARTICLE; CLINICAL FEATURE; DIALYSIS; DRUG INDUCED DISEASE; ELECTROLYTE BALANCE; FLUID BALANCE; HUMAN; NEPHROTOXICITY; PATHOPHYSIOLOGY; RENAL PROTECTION; RISK FACTOR; SEPSIS; TREATMENT WITHDRAWAL;

EID: 37249000041     PISSN: 09723560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gilbert DN. Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R, eds. Douglas and Bennett's Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995; 279-301.
2. Leehey DJ, Braun BI, Tholi DA et al. Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy? J Am Soc Nephrol 1993; 4: 81-90.
3. Gyselynck AM, Forrey A, Cutler R. Pharcmacokinetics of gentamicin: Distribution and plasma and renal clearance. J Infect Dis 1971; 124: 70-6.
4. Senekjian HO, Knight TF, Weinman EJ. Micro puncture study of the handling of gentamicin by the rat kidney. Kidney Int 1981; 19: 416-23.
5. Lacy MK, Nicolau DP, Nightingale CH, Quintiliani R. The pharmacodynamics of aminoglycosides. Clin Infect Dis 1998; 27: 23-7.
6. Turnidge J. Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin N Am 2003; 17: 503-28.
7. Gonzalez LS, Spencer JP. Aminoglycosides: a practical review. Am Fam Physician 1998; 58: 1811-20.
8. Houghton DC, English J, Bennett WM. Chronic tubulointerstitial nephritis and renal insufficiency associated with long-term sub-therapeutic gentamicin. J Lab Clin Med 1988; 112: 694-703.
9. Meinick JZ, Baum M, Thompson JR. Aminoglycoside-induced Fanconi's syndrome. Am J Kidney Dis 1994; 23; 118-22.
10. Foster JE, Harpur ES, Garland HO. An investigation of the acute effects of gentamicin on the renal handling of electrolytes in the rat. J Pharmacol Exp Ther 1992; 261: 38-43.
11. Moestrup SK, Cui S, Vorum H et al. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest 1995; 96: 1404-13.
12. Laurent G, Carlier MB, Rollman B et al. Mechanisms of aminoglycoside-induced lysosomal phospholipidosis: In vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol 1982; 31: 188-91.
13. Luft FC, Bloch R, Sloan RS et al. Comparativenephrotoxicity of aminoglycoside antibiotics on rats. J Infect Dis 1978; 138: 541-5.
14. Williams PD, Bennett DB Gleason CR et al. Correlation between renal membrane binding and nephrotoxicity of aminoglycosides. Antimicrob Agents Chemother 1987; 31: 570-4.
15. Swan SK. Aminoglycoside nephrotoxicity. Seminars in Nephrology 1997; 17: 27-33.
16. Morin JP, Viotte G, Vandewalle A et al. Gentamicin-induced nephrotoxicity: A cell biology approach. Kidney Int 1980; 18: 583-90.
17. Mingeot-Leclerq MP, Tulkem PM. Aminoglycosides: Nephrotoxicity. Antimicrob Agents Chemother 1999; 43: 1003-12.
18. Ali MZ, Goetz MB. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24: 796-809.
19. Thompson JR, Simonsen R, Spindler MA et al. Protective effects of KCl loading in gentamicin nephrotoxicity.
20. Kojima R, Ito M, Suzuki Y. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects(9): Protective effect of inositol hexasulfate against tobramycin-induced nephrotoxicity. Jpn J Pharmacol 1990; 53: 347-58.
21. Gibert DN, Wood CA, Kohlhepp SJ et al. Polyaspartic acid prevents experimental gentamicin nephrotoxicity. J Infect Dis 1989; 159: 945-53.
22. English J, Gilbert DN, Kohlhepp S et al. Attenuation of experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob Agents Chemother 1985; 27: 897-902.